Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Discov ; 11(1): 158-175, 2021 01.
Article in English | MEDLINE | ID: mdl-32847940

ABSTRACT

Agonistic antibodies targeting CD137 have been clinically unsuccessful due to systemic toxicity. Because conferring tumor selectivity through tumor-associated antigen limits its clinical use to cancers that highly express such antigens, we exploited extracellular adenosine triphosphate (exATP), which is a hallmark of the tumor microenvironment and highly elevated in solid tumors, as a broadly tumor-selective switch. We generated a novel anti-CD137 switch antibody, STA551, which exerts agonistic activity only in the presence of exATP. STA551 demonstrated potent and broad antitumor efficacy against all mouse and human tumors tested and a wide therapeutic window without systemic immune activation in mice. STA551 was well tolerated even at 150 mg/kg/week in cynomolgus monkeys. These results provide a strong rationale for the clinical testing of STA551 against a broad variety of cancers regardless of antigen expression, and for the further application of this novel platform to other targets in cancer therapy. SIGNIFICANCE: Reported CD137 agonists suffer from either systemic toxicity or limited efficacy against antigen-specific cancers. STA551, an antibody designed to agonize CD137 only in the presence of extracellular ATP, inhibited tumor growth in a broad variety of cancer models without any systemic toxicity or dependence on antigen expression.See related commentary by Keenan and Fong, p. 20.This article is highlighted in the In This Issue feature, p. 1.


Subject(s)
Adenosine Triphosphate , Neoplasms , Animals , Antibodies, Monoclonal/pharmacology , Antigens, Neoplasm , Immunotherapy , Mice , Neoplasms/drug therapy , Tumor Microenvironment , Tumor Necrosis Factor Receptor Superfamily, Member 9
2.
J Cell Sci ; 130(21): 3676-3684, 2017 Nov 01.
Article in English | MEDLINE | ID: mdl-28883092

ABSTRACT

Nonsense mutations in the ASPM gene have been most frequently identified among familial microcephaly patients. Depletion of the Drosophila orthologue (asp) causes spindle pole unfocusing during mitosis in multiple cell types. However, it remains unknown whether human ASPM has a similar function. Here, by performing CRISPR-based gene knockout (KO) and RNA interference combined with auxin-inducible degron, we show that ASPM functions in spindle pole organisation during mitotic metaphase redundantly with another microcephaly protein, CDK5RAP2 (also called CEP215), in human tissue culture cells. Deletion of the ASPM gene alone did not affect spindle morphology or mitotic progression. However, when the pericentriolar material protein CDK5RAP2 was depleted in ASPM KO cells, spindle poles were unfocused during prometaphase, and anaphase onset was significantly delayed. The phenotypic analysis of CDK5RAP2-depleted cells suggested that the pole-focusing function of CDK5RAP2 is independent of its known function to localise the kinesin-14 motor HSET (also known as KIFC1) or activate the γ-tubulin complex. Finally, a hypomorphic mutation identified in ASPM microcephaly patients similarly caused spindle pole unfocusing in the absence of CDK5RAP2, suggesting a possible link between spindle pole disorganisation and microcephaly.


Subject(s)
Intracellular Signaling Peptides and Proteins/genetics , Kinesins/genetics , Nerve Tissue Proteins/genetics , Spindle Poles/metabolism , Anaphase , CRISPR-Cas Systems , Cell Cycle Proteins , Gene Editing , Gene Expression Regulation , Gene Knockout Techniques , HCT116 Cells , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Kinesins/metabolism , Metaphase , Microcephaly/genetics , Microcephaly/metabolism , Microcephaly/pathology , Models, Biological , Nerve Tissue Proteins/deficiency , Nerve Tissue Proteins/metabolism , Signal Transduction , Spindle Poles/ultrastructure , Tubulin/genetics , Tubulin/metabolism
3.
J Cell Biol ; 211(5): 999-1009, 2015 Dec 07.
Article in English | MEDLINE | ID: mdl-26644514

ABSTRACT

Depletion of Drosophila melanogaster Asp, an orthologue of microcephaly protein ASPM, causes spindle pole unfocusing during mitosis. However, it remains unclear how Asp contributes to pole focusing, a process that also requires the kinesin-14 motor Ncd. We show that Asp localizes to the minus ends of spindle microtubule (MT) bundles and focuses them to make the pole independent of Ncd. We identified a critical domain in Asp exhibiting MT cross-linking activity in vitro. Asp was also localized to, and focuses the minus ends of, intraspindle MTs that were nucleated in an augmin-dependent manner and translocated toward the poles by spindle MT flux. Ncd, in contrast, functioned as a global spindle coalescence factor not limited to MT ends. We propose a revised molecular model for spindle pole focusing in which Asp at the minus ends cross-links MTs at the pole and within the spindle. Additionally, this study provides new insight into the dynamics of intraspindle MTs by using Asp as a minus end marker.


Subject(s)
Drosophila Proteins/physiology , Microtubule-Associated Proteins/physiology , Microtubules/metabolism , Spindle Apparatus/metabolism , Animals , Brain , Cross-Linking Reagents/chemistry , Drosophila melanogaster , Green Fluorescent Proteins/metabolism , Immunoblotting , Microscopy , Microscopy, Confocal , Phenotype , Protein Structure, Tertiary , RNA Interference , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...